A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin
- 1 August 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 129 (2) , 258-263
- https://doi.org/10.1016/s0022-3476(96)70251-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Assessment of iron status in infantsActa Paediatrica, 1995
- Intravenous Iron Administration to Very‐Low‐Birth‐Weight Newborns Receiving Total and Partial Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 1995
- Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: A randomized, placebo-controlled trialThe Journal of Pediatrics, 1995
- Recombinant Human Erythropoietin Stimulates Erythropoiesis and Reduces Erythrocyte Transfusions in Very Low Birth Weight Preterm InfantsPediatrics, 1995
- Recombinant Human Erythropoietin in the Treatment of the Anemia of Prematurity: Results of a Double-Blind, Placebo-Controlled StudyPediatrics, 1994
- The Effect of Epoetin Beta (Recombinant Human Erythropoietin) on the Need for Transfusion in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1994
- Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.Archives of Disease in Childhood, 1993
- Empiric red cell transfusion in asymptomatic preterm infantsActa Paediatrica, 1993
- Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infantsThe Journal of Pediatrics, 1992
- Iron status of preterm low birthweight infants and their response to oral ironArchives of Disease in Childhood, 1974